• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4826761)   Today's Articles (6857)
For: Hu WG, Chen J, Battey JF, Gu XX. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect Immun 2000;68:4980-5. [PMID: 10948114 PMCID: PMC101715 DOI: 10.1128/iai.68.9.4980-4985.2000] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
Number Cited by Other Article(s)
1
Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae. Vaccine 2020;38:309-317. [PMID: 31668366 DOI: 10.1016/j.vaccine.2019.10.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2018] [Revised: 09/23/2019] [Accepted: 10/04/2019] [Indexed: 11/21/2022]
2
Micoli F, Costantino P, Adamo R. Potential targets for next generation antimicrobial glycoconjugate vaccines. FEMS Microbiol Rev 2018;42:388-423. [PMID: 29547971 PMCID: PMC5995208 DOI: 10.1093/femsre/fuy011] [Citation(s) in RCA: 118] [Impact Index Per Article: 16.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Accepted: 03/13/2018] [Indexed: 12/21/2022]  Open
3
Perez AC, Murphy TF. A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges. Hum Vaccin Immunother 2017;13:2322-2331. [PMID: 28853985 PMCID: PMC5647992 DOI: 10.1080/21645515.2017.1356951] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2017] [Revised: 06/16/2017] [Accepted: 07/12/2017] [Indexed: 01/03/2023]  Open
4
Giebink GS, Bakaletz LO, Barenkamp SJ, Green B, Gu XX, Heikkinen T, Hotomi M, Karma P, Kurono Y, Kyd JM, Murphy TF, Ogra PL, Patel JA, Pelton SI. 6. Vaccine. Ann Otol Rhinol Laryngol 2016. [DOI: 10.1177/00034894051140s110] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
5
Murphy TF, Brauer AL, Johnson A, Kirkham C. ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence. PLoS One 2016;11:e0158689. [PMID: 27391026 PMCID: PMC4938438 DOI: 10.1371/journal.pone.0158689] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2016] [Accepted: 06/20/2016] [Indexed: 11/24/2022]  Open
6
Augustyniak D, Piekut M, Majkowska-Skrobek G, Skała J. Bactericidal, opsonophagocytic and anti-adhesive effectiveness of cross-reactive antibodies against Moraxella catarrhalis. Pathog Dis 2015;73:ftu026. [PMID: 25743473 DOI: 10.1093/femspd/ftu026] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
7
Mawas F, Ho MM, Corbel MJ. Current progress withMoraxella catarrhalisantigens as vaccine candidates. Expert Rev Vaccines 2014;8:77-90. [DOI: 10.1586/14760584.8.1.77] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
8
Akgul G, Erturk A, Turkoz M, Turan T, Ichinose A, Nagatake T, Ahmed K. Role of Lipooligosaccharide in the Attachment ofMoraxella catarrhalisto Human Pharyngeal Epithelial Cells. Microbiol Immunol 2013;49:931-5. [PMID: 16237271 DOI: 10.1111/j.1348-0421.2005.tb03685.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
9
Gao S, Ren D, Peng D, Zhang W, Muszyński A, Carlson RW, Gu XX. Late acyltransferase genes lpxX and lpxL jointly contribute to the biological activities of Moraxella catarrhalis. J Med Microbiol 2013;62:807-812. [PMID: 23475908 DOI: 10.1099/jmm.0.056846-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
10
Su YC, Singh B, Riesbeck K. Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol 2013;7:1073-100. [PMID: 22953708 DOI: 10.2217/fmb.12.80] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]  Open
11
Ren D, Xie H, Zhang W, Hassan F, Petralia RS, Yu S, Lim DJ, Gu XX. Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis. PLoS One 2011;6:e29553. [PMID: 22216312 PMCID: PMC3245267 DOI: 10.1371/journal.pone.0029553] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2011] [Accepted: 11/30/2011] [Indexed: 11/25/2022]  Open
12
Synthesis of a novel pentasaccharide core component from the lipooligosaccharide of Moraxella catarrhalis. Carbohydr Res 2011;346:2805-11. [DOI: 10.1016/j.carres.2011.10.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2010] [Revised: 09/29/2011] [Accepted: 10/03/2011] [Indexed: 11/18/2022]
13
Cox AD, St. Michael F, Cairns CM, Lacelle S, Filion AL, Neelamegan D, Wenzel CQ, Horan H, Richards JC. Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera. Glycoconj J 2011;28:165-82. [DOI: 10.1007/s10719-011-9332-7] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2011] [Revised: 03/22/2011] [Accepted: 03/23/2011] [Indexed: 10/18/2022]
14
Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies. Infect Immun 2009;77:4548-58. [PMID: 19651870 DOI: 10.1128/iai.00294-09] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]  Open
15
Gao S, Peng D, Zhang W, Muszyński A, Carlson RW, Gu XX. Identification of two late acyltransferase genes responsible for lipid A biosynthesis in Moraxella catarrhalis. FEBS J 2008;275:5201-14. [PMID: 18795947 DOI: 10.1111/j.1742-4658.2008.06651.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
16
Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination. Infect Immun 2008;76:4251-8. [PMID: 18559429 DOI: 10.1128/iai.01570-07] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
17
Peng D, Hu WG, Choudhury BP, Muszyński A, Carlson RW, Gu XX. Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane. FEBS J 2007;274:5350-9. [PMID: 17892485 DOI: 10.1111/j.1742-4658.2007.06060.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
18
Murphy TF. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines 2007;4:843-53. [PMID: 16372880 DOI: 10.1586/14760584.4.6.843] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
19
Yu S, Gu XX. Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis. Infect Immun 2007;75:2974-80. [PMID: 17371852 PMCID: PMC1932890 DOI: 10.1128/iai.01915-06] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
20
Gergova RT, Iankov ID, Haralambieva IH, Mitov IG. Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp. Curr Microbiol 2007;54:85-90. [PMID: 17211546 DOI: 10.1007/s00284-005-0463-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2005] [Accepted: 04/18/2006] [Indexed: 10/23/2022]
21
Wu T, Chen J, Murphy TF, Green BA, Gu XX. Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines. Vaccine 2006;23:5177-85. [PMID: 16039021 DOI: 10.1016/j.vaccine.2005.06.014] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2004] [Revised: 06/06/2005] [Accepted: 06/14/2005] [Indexed: 11/28/2022]
22
Wieland CW, Florquin S, Maris NA, Hoebe K, Beutler B, Takeda K, Akira S, van der Poll T. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung. THE JOURNAL OF IMMUNOLOGY 2005;175:6042-9. [PMID: 16237099 DOI: 10.4049/jimmunol.175.9.6042] [Citation(s) in RCA: 123] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
23
Edwards KJ, Allen S, Gibson BW, Campagnari AA. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J Bacteriol 2005;187:2939-47. [PMID: 15838019 PMCID: PMC1082826 DOI: 10.1128/jb.187.9.2939-2947.2005] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]  Open
24
Furano K, Luke NR, Howlett AJ, Campagnari AA. Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. MICROBIOLOGY-SGM 2005;151:1151-1158. [PMID: 15817782 DOI: 10.1099/mic.0.27820-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
25
Yu S, Gu XX. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis. Infect Immun 2005;73:2790-6. [PMID: 15845482 PMCID: PMC1087343 DOI: 10.1128/iai.73.5.2790-2796.2005] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
26
Jones C. Vaccines based on the cell surface carbohydrates of pathogenic bacteria. AN ACAD BRAS CIENC 2005;77:293-324. [PMID: 15895165 DOI: 10.1590/s0001-37652005000200009] [Citation(s) in RCA: 130] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]  Open
27
Hu WG, Berry J, Chen J, Gu XX. Exploration ofMoraxella catarrhalisouter membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates. ACTA ACUST UNITED AC 2004;41:109-15. [PMID: 15145454 DOI: 10.1016/j.femsim.2004.02.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2003] [Revised: 12/10/2003] [Accepted: 02/04/2004] [Indexed: 11/26/2022]
28
Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, Kang SH, Li JD, Nagura M, Ganz T, Lim DJ. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 2004;4:12. [PMID: 15125783 PMCID: PMC428576 DOI: 10.1186/1471-2334-4-12] [Citation(s) in RCA: 101] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2003] [Accepted: 05/05/2004] [Indexed: 11/10/2022]  Open
29
Jiao X, Hirano T, Hou Y, Gu XX. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine. Infect Immun 2002;70:5982-9. [PMID: 12379673 PMCID: PMC130355 DOI: 10.1128/iai.70.11.5982-5989.2002] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2002] [Revised: 06/05/2002] [Accepted: 08/05/2002] [Indexed: 11/20/2022]  Open
30
Hou Y, Hu WG, Hirano T, Gu XX. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model. Vaccine 2002;20:2375-81. [PMID: 12009294 DOI: 10.1016/s0264-410x(02)00097-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
31
Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev 2002;15:125-44. [PMID: 11781271 PMCID: PMC118065 DOI: 10.1128/cmr.15.1.125-144.2002] [Citation(s) in RCA: 219] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
32
Snow JB. Progress in the prevention of otitis media through immunization. Otol Neurotol 2002;23:1-2. [PMID: 11773835 DOI: 10.1097/00129492-200201000-00001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
33
Horner AA, Datta SK, Takabayashi K, Belyakov IM, Hayashi T, Cinman N, Nguyen MD, Van Uden JH, Berzofsky JA, Richman DD, Raz E. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2001;167:1584-91. [PMID: 11466380 DOI: 10.4049/jimmunol.167.3.1584] [Citation(s) in RCA: 89] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
34
Hu WG, Chen J, McMichael JC, Gu XX. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis. Infect Immun 2001;69:1358-63. [PMID: 11179299 PMCID: PMC98028 DOI: 10.1128/iai.69.3.1358-1363.2001] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA